Evidence map›Paper›PMID 31651593›Full record

Trial reportOptometry and vision science : official publication of the American Academy of Optometry2019

Treatment of Symptomatic Convergence Insufficiency in Children Enrolled in the Convergence Insufficiency Treatment Trial-Attention & Reading Trial: A Randomized Clinical Trial.

CITT-ART Investigator Group

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Optometry and vision science : official publication of the American Academy of Optometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Interventions for convergence insufficiency: a network meta-analysis.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Objective evaluation of fusional vergence after a vision therapy protocol in typical binocular vision.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Trial
  4. One-year follow-up of clinical convergence measures in children enrolled in the Convergence Insufficiency Treatment Trial-Attention and Reading Trial.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2024
    Trial
  5. Trial
  6. Effects of vision therapy on near exodeviation in children with convergence insufficiency treated during the convergence insufficiency treatment trials.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2024
    Trial
  7. Trial
  8. Trial
  9. Effectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2021
    Trial
  10. Convergence Insufficiency Neuro-mechanism in Adult Population Study Randomized Clinical Trial: Clinical Outcome Results.Optometry and vision science : official publication of the American Academy of Optometry · 2020
    Trial
  11. Effect of Vergence/Accommodative Therapy on Reading in Children with Convergence Insufficiency: A Randomized Clinical Trial.Optometry and vision science : official publication of the American Academy of Optometry · 2019
    Trial
  12. Article
  13. Long-term test and retest reliability of clinical vergence testing.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Article
  14. Post-concussion clinical findings of oculomotor function in paediatric patients with persisting symptoms compared to healthy controls.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

CITT-ART Investigator Group

Funding

Convergence Insufficiency Treatment Trial - Attention and Reading TrialU10EY022599 · NEI · SALUS UNIVERSITY · PI SCHEIMAN, MITCHELL M · 2014 to 2018
$2.2M
Convergence Insufficiency Treatment Trial- Attention and Reading Trial (CITT-ART)U10EY022601 · NEI · OHIO STATE UNIVERSITY · PI MITCHELL, GLADYS L · 2014 to 2018
$1.5M
Convergence Insuffiency Treatment Trial - Attention and Reading TrialU10EY022586 · NEI · STATE COLLEGE OF OPTOMETRY · PI SCHULMAN, ERICA · 2014 to 2018
$791k
Convergence Insufficiency Treatment Trial - Attention and Reading TrialU10EY022595 · NEI · SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY · PI COTTER, SUSAN ANNE · 2014 to 2018
$729k
The Convergence Insufficiency Treatment Trial - Attention and Reading TrialU10EY022600 · NEI · CHILDREN'S HOSPITAL MED CTR OF AKRON · PI HERTLE, RICHARD W · 2014 to 2018
$693k
Convergence Infufficency Treatment Trial - Attention and Reading Trial (CITT-ART)U10EY022592 · NEI · OHIO STATE UNIVERSITY · PI KULP, MARJEAN T · 2014 to 2018
$609k
Convergence Insufficiency Treatment Trial - Attention and Reading TrialU10EY022587 · NEI · SALUS UNIVERSITY · PI GALLAWAY, MICHAEL · 2014 to 2018
$577k
Convergence Insufficiency Treatment Trial - Attention and Reading TrialU10EY022596 · NEI · NOVA SOUTHEASTERN UNIVERSITY · PI COULTER, RACHEL ANASTASIA · 2014 to 2018
$513k
Convergence Insufficiency Treatment Trial Attention and Reading Trial (CITT-ART)U10EY022591 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TAMKINS, SUSANNA M · 2014 to 2018
$439k
Convergence Insufficiency Treatment Trial - Attention and Reading TrialU10EY022594 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HOPKINS, KRISTINE BECKER · 2014 to 2018
$438k
NEI NIH HHS U10 EY022586NEI NIH HHS U10 EY022587NEI NIH HHS U10 EY022591NEI NIH HHS U10 EY022592NEI NIH HHS U10 EY022594NEI NIH HHS U10 EY022595NEI NIH HHS U10 EY022596NEI NIH HHS U10 EY022599NEI NIH HHS U10 EY022600NEI NIH HHS U10 EY022601
6 · The paper itself

Abstract

significanceThese data confirm the effectiveness of office-based vergence/accommodative therapy for improving convergence in children with symptomatic convergence insufficiency. They also highlight the importance of using a primary outcome measure that is as objective as possible rather than relying solely on self-reported symptoms for studies of binocular vision in children. PURPOSE: The purpose of this study was to report changes in clinical signs and symptoms of convergence insufficiency (secondary outcome measures) from a multicenter clinical trial (Convergence Insufficiency Treatment Trial-Attention & Reading Trial [CITT-ART]) evaluating the effectiveness of vergence/accommodative therapy for improving reading and attention in children with symptomatic convergence insufficiency.

methodsThree hundred eleven children aged 9 to 14 years with symptomatic convergence insufficiency were randomly assigned to 16 weeks of office-based vergence/accommodative therapy or to placebo therapy. Improvements in (1) near point of convergence (NPC), (2) positive fusional vergence (PFV), and (3) self-reported symptoms (Convergence Insufficiency Symptom Survey [CISS] score) were compared after 16 weeks of treatment.

resultsMean NPC improved 10.4 cm in the vergence/accommodative and 6.2 cm in the placebo therapy group (mean difference of -4.2 cm [95% confidence interval {CI}, -5.2 to -3.2 cm; P < .001]); mean PFV increased 23.2 and 8.8Δ in the vergence/accommodative and placebo therapy groups, respectively (mean difference of 14.4Δ [95% CI, 12.1 to 16.8Δ; P < .001]). The mean CISS score improved 11.8 and 10.4 points in the vergence/accommodative and placebo therapy groups, respectively (mean difference of 1.5 points [95% CI, -3.8 to +0.8 points; P = .21]).

conclusionsOur results demonstrate that office-based vergence/accommodative therapy is effective for improving the NPC and PFV in children with symptomatic convergence insufficiency. However, given that both treatment groups had a similar reduction in self-reported symptoms, it may not be prudent to use the CISS alone as a measure of successful treatment.

Indexed as

ReadingAccommodation, OcularAdolescentAttentionChildConvergence, OcularDouble-Blind MethodFemaleHumansMaleOcular Motility DisordersOrthopticsSelf ReportVision, Binocular

Identifiers

PMID31651593
PMCPMC6855327
OpenAlexW4205684519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.